KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Non-Current Deferred Tax Liability (2016 - 2025)

Historic Non-Current Deferred Tax Liability for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to -$526.1 million.

  • Gsk's Non-Current Deferred Tax Liability fell 3773.21% to -$526.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$526.1 million, marking a year-over-year decrease of 3773.21%. This contributed to the annual value of -$488.3 million for FY2024, which is 22623.18% down from last year.
  • Latest data reveals that Gsk reported Non-Current Deferred Tax Liability of -$526.1 million as of Q3 2025, which was down 3773.21% from -$512.3 million recorded in Q2 2025.
  • Gsk's 5-year Non-Current Deferred Tax Liability high stood at $4.8 billion for Q4 2021, and its period low was -$5.1 billion during Q3 2021.
  • In the last 5 years, Gsk's Non-Current Deferred Tax Liability had a median value of -$490.3 million in 2024 and averaged -$1.0 billion.
  • As far as peak fluctuations go, Gsk's Non-Current Deferred Tax Liability skyrocketed by 9625.75% in 2022, and later crashed by 23345.18% in 2023.
  • Quarter analysis of 5 years shows Gsk's Non-Current Deferred Tax Liability stood at $4.8 billion in 2021, then tumbled by 92.93% to $339.0 million in 2022, then rose by 13.87% to $386.0 million in 2023, then crashed by 227.02% to -$490.3 million in 2024, then decreased by 7.31% to -$526.1 million in 2025.
  • Its last three reported values are -$526.1 million in Q3 2025, -$512.3 million for Q2 2025, and -$508.8 million during Q1 2025.